President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.
The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback